Related Articles
<em>O</em>‑GlcNAcylation mediates endometrial cancer progression by regulating the Hippo‑YAP pathway
Fatostatin suppresses growth and enhances apoptosis by blocking SREBP-regulated metabolic pathways in endometrial carcinoma
Activation of AMPK pathway by low‑dose donafenib and atorvastatin combination improves high‑fat diet‑induced metabolic dysfunction‑associated steatotic liver disease
The role of lncRNAs in the development of endometrial carcinoma (Review)
Significance of calreticulin as a prognostic factor in endometrial cancer